Abstrakt

Przypisy

• 1. Atrasheuskaya A.V., Fredeking T.M., Ignatyev G.M.: Changes inimmune parameters and their correction in human cases of tick–borne encephalitis. Clin. Exp. Immunol., 2003; 131: 148-154
  Google Scholar
• 2. Barkhash A.V., Perelygin A.A., Babenko V.N., Brinton M.A., VoevodaM.I.: Single nucleotide polymorphism in the promoter regionof the CD209 gene is associated with human predisposition to severeforms of tick- borne encephalitis. Antiviral Res., 2012; 93: 64-68
  Google Scholar
• 3. Czupryna P., Moniuszko A., Pancewicz S.A., Grygorczuk S., KondrusikM., Zajkowska J.: Tick-borne encephalitis in Poland in years1993-2008 – epidemiology and clinical presentation. A retrospectivestudy of 687 patients. Eur. J. Neurol., 2011; 18: 673-679
  Google Scholar
• 4. Ge D., Fellay J., Thompson A.J., Simon J.S., Shianna K.V., UrbanT.J., Heinzen E.L., Qiu P., Bertelsen A.H., Muir A.J., Sulkowski M.,McHutchison J.G., Goldstein D.B.: Genetic variation in IL28B predictshepatitis C treatment-induced viral clearance. Nature, 2009;461: 399-401 5 Glass W.G., McDermott D.H., Lim J.K., Lekhong S., Yu S.F., Frank W.A.,Pape J., Cheshier R.C., Murphy P.M.: CCR5 deficiency increases risk ofsymptomatic West Nile virus infection. J. Exp. Med., 2006; 203: 35-40
  Google Scholar
• 5. (CCR5) gene is associated with tickborne encephalitis. J. Infect.Dis., 2008; 1975: 266-269
  Google Scholar
• 6. Grebely J., Petoumenos K., Hellard M., Matthews G.V., SuppiahV., Applegate T., Yeung B., Marks P., Rawlinson W., Lloyd A.R., BoothD., Kaldor J.M., George J., Dore G.J., ATAHC Study Group: Potentialrole for interleukin-28B genotype in treatment decision-making inrecent hepatitis C virus infection. Hepatology, 2010; 52: 1216-1224
  Google Scholar
• 7. Günther G., Haglund M., Lindquist L., Forsgren M., Andersson J.,Andersson B., Sköldenberg B.: Tick-borne encephalitis is associatedwith low levels of interleukin-10 in cerebrospinal fluid. Infect. Ecol.Epidemiol., 2011; 1: 6029
  Google Scholar
• 8. Ignat’ev G.M., Otrashevskaia E.V., Vorob’eva M.C.: Cytokine productionduring experimental infection of mice with tick-borne encephalitisvirus. Vopr. Virusol., 2003; 48: 18-21
  Google Scholar
• 9. Kaiser R.: Tick-borne encephalitis: Clinical findings and prognosisin adults. Wien. Med. Wochenschr., 2012; 162: 239-243
  Google Scholar
• 10. Kindberg E., Mickiene A., Ax C., Akerlind B., Vene S., LindquistL., Lundkvist A., Svensson L.: A deletion in the chemokine receptor
  Google Scholar
• 11. Kristiansen T.B., Knudsen T.B., Ohlendorff S., Eugen-Olsen J.:A new multiplex PCR strategy for the simultaneous determinationof four genetic polymorphisms affecting HIV-1 disease progression.J. Immunol. Methods, 2001; 252: 147-151
  Google Scholar
• 12. Labuda M., Austyn J.M., Zuffova E., Kozuch O., Fuchsberger N.,Lysy J., Nuttall P.A.: Importance of localized skin infection in tickborneencephalitis virus transmission. Virology, 1996; 219: 357-366
  Google Scholar
• 13. Li J., Liu Y., Xu F., Chen J., Chen Y.: Three polymorphisms in theIL-10 gene and the risk of HCV infection: a meta-analysis plus a ChineseAssociation Study involving 1140 subjects. Epidemiol. Infect.,2013; 141: 893-904
  Google Scholar
• 14. Libraty D.H., Endy T.P., Houng H.S., Green S., Kalayanarooj S.,Suntayakorn S., Chansiriwongs W., Vaughn D.W., Nisalak A., EnnisF.A., Rothman A.L.: Differing influences of virus burden and immuneactivation on disease severity in secondary dengue-3 virus infections.J. Infect. Dis., 2002; 185: 1213-1221
  Google Scholar
• 15. Lim J.K., Louie C.Y., Glaser C., Jean C., Johnson B., Johnson H.,McDermott D.H., Murphy P.M.: Genetic deficiency of chemokine receptorCCR5 is a strong risk factor for symptomatic West Nile Virusinfection: a meta-analysis of 4 cohorts in the US epidemics. J. Infect.Dis., 2008; 197: 262-265
  Google Scholar
• 16. Lim J.K., McDermott D.H., Lisco A., Foster G.A., Krysztof D., FollmannD., Stramer S.L., Murphy P.M.: CCR5 deficiency is a risk factorfor early clinical manifestations of West Nile virus infection but notfor viral transmission. J. Infect. Dis., 2010; 201: 178-185
  Google Scholar
• 17. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R.,MacDonald M.E., Stuhlmann H., Koup R.A., Landau N.R.: Homozygousdefect in HIV-1 coreceptor accounts for resistance of some multiply-exposedindividuals to HIV-1 infection. Cell, 1996; 86: 367-377
  Google Scholar
• 18. Loeb M., Eskandarian S., Rupp M., Fishman N., Gasink L., PattersonJ., Bramson J., Hudson T.J., Lemire M.: Genetic variants andsusceptibility to neurological complications following West Nilevirus infection. J. Infect. Dis., 2011; 204: 1031-1037
  Google Scholar
• 19. Lucotte G.: Frequencies of 32 base pair deletion of the (Δ32) alleleof the CCR5 HIV-1 co-receptor gene in Caucasians: a comparativeanalysis. Infect. Genet. Evol., 2002; 1: 201-205
  Google Scholar
• 20. Mege J.L., Meghari S., Honstettre A., Capo C., Raoult D.: The twofaces of interleukin 10 in human infectious diseases. Lancet Infect.Dis., 2006; 6: 557-569
  Google Scholar
• 21. Patterson B.K., Czerniewski M., Andersson J., Sullivan Y., Su F.,Jiyamapa D., Burki Z., Landay A.: Regulation of CCR5 and CXCR4 expressionby type 1 and type 2 cytokines: CCR5 expression is downregulatedby IL-10 in CD4-positive lymphocytes. Clin. Immunol.,1999; 91: 254-262
  Google Scholar
• 22. PZH, www. pzh. gov.pl (20.10.2015)
  Google Scholar
• 23. Ryan E.J., Dring M., Ryan C.M., McNulty C., Stevenson N.J., LawlessM.W., Crowe J., Nolan N., Hegarty J.E., O’Farrelly C.: Variant inCD209 promoter is associated with severity of liver disease in chronichepatitis C virus infection. Hum. Immunol., 2010; 71: 829-832
  Google Scholar
• 24. SNPedia. rs 2287886. www.snpedia.com/index.php/Rs2287886(18.07.2015)
  Google Scholar
• 25. Sun X.R., Wu J., Shi K.Q., Tang K.F.: Relationship between IL-10gene -1082A/G and -592C/A polymorphisms and the risk of hepatitisC infection: a meta-analysis. J. Viral. Hepat., 2013; 20: 602-611
  Google Scholar
• 26. Tanaka Y., Nishida N., Sugiyama M., Kurosaki M., Matsuura K.,Sakamoto N., Nakagawa M., Korenaga M., Hino K., Hige S., Ito Y., MitaE., Tanaka E., Mochida S., Murawaki Y., et al.: Genome-wide associationof IL-28B with response to pegylated interferon-α and ribavirintherapy for chronic hepatitis C. Nat. Genet., 2009; 41: 1105-1109
  Google Scholar
• 27. Ubol S., Masrinoul P., Chaijaruwanich J., Kalayanarooj S., CharoensirisuthikulT., Kasisith J.: Differences in global gene expressionin peripheral blood mononuclear cells indicate a significant role ofthe innate responses in progression of dengue fever but not denguehaemorrhagic fever. J. Infect. Dis., 2008; 197: 1459-1467
  Google Scholar
• 28. Wang L., Chen R.F., Liu J.W., Lee I.K., Lee C.P., Kuo H.C., HuangS.K., Yang K.D.: DC-SIGN (CD209) Promoter -336 A/G polymorphismis associated with dengue hemorrhagic fever and correlated to DCSIGNexpression and immune augmentation. PLoS Negl. Trop. Dis.,2011; 5: e934
  Google Scholar
• 29. Zambito Marsala S., Pistacchi M., Gioulis M., Mel R., Marchini C.,Francavilla E.: Neurological complications of tick borne encephalitis:the experience of 89 patients studied and literature review. Neurol.Sci., 2014; 35: 15-21
  Google Scholar

Pełna treść artykułu